Morgan Stanley
IDIX

Morgan Stanley’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Morgan Stanley’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,660,196
Closed -$40M – 6873
2014
Q2 		$40M Buy
1,660,196
+1,473,978
+792% +$15.4M 0.02% 929
2014
Q1 		$1.12M Sell
186,218
-22,639
-11% -$158K ﹤0.01% 3889
2013
Q4 		$1.25M Buy
208,857
+76,885
+58% +$356K ﹤0.01% 3748
2013
Q3 		$684K Sell
131,972
-17,110
-11% -$75K ﹤0.01% 4110
2013
Q2 		$538K Buy
+149,082
New +$610K ﹤0.01% 4208

Morgan Stanley's IDIX Position: Q3 2014 in Review

Morgan Stanley sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 1,660,196 shares — an estimated $40M sold.

Morgan Stanley first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $40M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Morgan Stanley reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Morgan Stanley sold 1,660,196 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $40M.
  • Morgan Stanley first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Morgan Stanley's IDENIX PHARMACEUTICALS INC position peaked at $40M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Morgan Stanley's 13F filing for Q3 2014, filed 14 Nov 2014.